Ocugen to Present at BIO International Convention 2024 tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
BRIDGEWATER, NJ / ACCESSWIRE / May 29, 2024 / Tharimmune, Inc. (NASDAQ:THAR) ("Tharimmune" or the "Company"), a clinical-stage biotechnology company developing a portfolio of therapeutic candidates in
/PRNewswire/ Conformal Medical, Inc. announced today the positive one-year results from the company s CONFORMAL Early Feasibility Study (EFS). Dr. William.
Supira's technology features a novel low profile, high continuous flow design that aims to provide full hemodynamic support for high-risk percutaneous coronary interventions (HRPCI) and cardiogenic shock (CS) patients with a single device
/PRNewswire/ Supira Medical, Inc., a Shifamed portfolio company, announced today that the company s percutaneous ventricular assist device (pVAD) will be.